Analyst Ratings for Theravance Biopharma (TBPH)
TBPH Rating Summary
TBPH Price Target Summary
- Highest: $42.00 (Jones Trading)
- Lowest: $13.00 (Leerink Partners)
- Average: $21.67
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$21.67 (+59.7%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 41%
Avg. $ Target:
$21.67 (+59.7%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 41%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/5/2026 | Oppenheimer | Trevor Allred | Downgrade | Perform (Outperform) |
N/A (N/A) |
13.67 (13.57) |
-0.73% | Details |
| 3/4/2026 | B.Riley | Mayank Mamtani | Downgrade | Neutral (Buy) |
14.00 (28.00) |
18.95 (13.57) |
-28.39% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
